Profile
| Metric | Value |
|---|---|
| Full Name | Bolt Biotherapeutics, Inc. |
| Ticker | NASDAQ: BOLT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | boltbio.com |
| Employees | 52 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $6.63 | |
| Price, 1D Change | +2.85% | |
| $13M | ||
| - | ||
| - | ||
| 0.99 | ||
| $8M | ||
| Revenue, 1Y Change | -2.36% | |
| -$33.06 | ||
| EPS, 1Y Change | -1,706.56% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$33.06 | ||
| EPS Estimate | N/A | -$23.67 |
| EPS Est. Change | N/A | +28.40% |
| $7.69M | ||
| Revenue Estimate | N/A | $6.05M |
| Revenue Est. Change | N/A | -21.34% |
| Current Price | $6.63 | |
| Price Target | - | $6.00 |
| Price Tgt. Change | - | -9.56% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.83 | -$1.83 | 0.00% | |
| -$1.50 | -$33.06 | -2,104.00% | |
| -$23.67 | N/A | +28.40% | |
| -$20.24 | N/A | +38.78% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $7.59M | $7.88M | +3.77% | |
| $8.48M | $7.69M | -9.35% | |
| $6.05M | N/A | -21.34% | |
| $4.43M | N/A | -42.35% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $6.63 | |
| $5.85 | ||
| SMA 200 vs Price | -11.84% | |
| $5.27 | ||
| SMA 50 vs Price | -20.56% | |
| 0.99 | ||
| $0.37 | ||
| 69.81 | ||
| 52.20% | ||
| 67.07% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $7.69M | ||
| -$33.06 | ||
| $5.51M | ||
| 71.64% | ||
| -$68.24M | ||
| -887.33% | ||
| -$63.12M | ||
| -820.78% | ||
| -$66.46M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.44 | ||
| 3.20 | ||
| 3.20 | ||
| - | ||
| 2 | ||
| -7.59 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 2.45 | ||
| 0.40 | ||
| -0.08 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $57.20M | ||
| $7.21M | ||
| $99.63M | ||
| $50.81M | ||
| $42.43M | ||
| $15.86M | ||
| $25.21M | ||
| $2.25M | ||
| $1.51M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $75.93M | ||
| $75.93M | ||
| $2.18M | ||
| $18.46M | ||
| $1.78M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$61.29M | ||
| $57.58M | ||
| $108.00K | ||
| $41.00K | ||
| -$61.33M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Lake Street | → | |
| Lake Street | ||
| Stifel | → | |
| Stifel | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | ||
| HC Wainwright & Co. | ||
| Stifel | → | |
| Leerink Partners | → | |
| Jones Trading | → |
Analyst sentiment
Institutional ownership
Screeners with BOLT
Data Sources & References
- BOLT Official Website www.boltbio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1641281/000095017025043873/0000950170-25-043873-index.htm
- BOLT Profile on Yahoo Finance finance.yahoo.com/quote/BOLT
- BOLT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bolt
FAQ
What is the ticker symbol for Bolt Biotherapeutics, Inc.?
The ticker symbol for Bolt Biotherapeutics, Inc. is NASDAQ:BOLT
Does Bolt Biotherapeutics, Inc. pay dividends?
No, Bolt Biotherapeutics, Inc. does not pay dividends
What sector is Bolt Biotherapeutics, Inc. in?
Bolt Biotherapeutics, Inc. is in the Healthcare sector
What industry is Bolt Biotherapeutics, Inc. in?
Bolt Biotherapeutics, Inc. is in the Biotechnology industry
What country is Bolt Biotherapeutics, Inc. based in?
Bolt Biotherapeutics, Inc. is headquartered in United States
When did Bolt Biotherapeutics, Inc. go public?
Bolt Biotherapeutics, Inc. initial public offering (IPO) was on February 5, 2021
Is Bolt Biotherapeutics, Inc. in the S&P 500?
No, Bolt Biotherapeutics, Inc. is not included in the S&P 500 index
Is Bolt Biotherapeutics, Inc. in the NASDAQ 100?
No, Bolt Biotherapeutics, Inc. is not included in the NASDAQ 100 index
Is Bolt Biotherapeutics, Inc. in the Dow Jones?
No, Bolt Biotherapeutics, Inc. is not included in the Dow Jones index
When was Bolt Biotherapeutics, Inc. last earnings report?
Bolt Biotherapeutics, Inc.'s most recent earnings report was on August 14, 2025
When does Bolt Biotherapeutics, Inc. report earnings?
The date for Bolt Biotherapeutics, Inc.'s next earnings report has not been announced yet